Navigation Links
DrugRisk Update: Byetta Maker Agrees With Transferring Lawsuits to Federal Court

Sacramento, CA (PRWEB) May 14, 2013

The diabetes drug safety advocates at are announcing updated information for patients who have taken the medication Byetta. The maker of the drug has agreed with moving the growing number of injury claims to a special federal court in California*.

DrugRisk was created to improve the safety of those taking popular prescription drugs by providing the latest warnings, recalls, studies and legal news. Patients can see if others are experiencing similar side effects and decide if they need legal advice.

Byetta is a twice-daily injectable medication released in 2005 to help those with type-2 diabetes control blood sugar. It generated sales of over $300 million last year, when it was purchased with Amylin Pharmaceuticals by Bristol-Myers Squibb**.

However, DrugRisk has added a 2011 study from UCLA indicating Byetta could increase the risk of pancreatic cancer by 290% and thyroid cancer by 473%***. The Journal for the American Medical Association also recently warned these drugs can double the risk of pancreatitis, a major risk factor for pancreatic cancer****.

Due to the number of patients filing a Byetta lawsuit alleging cancer, lawyers have asked that cases be consolidated to a special federal multi-district court in California*****. (In Re: Incretins Products Liability, Sales and Marketing Litigation, MDL 2452, United States Judicial Panel on Multidistrict Litigation).

Now, DrugRisk has learned that Amylin and Eli Lilly have filed a response agreeing to the transfer to the federal court*. The resource center believes this could expedite the legal process for both the companies and patients alleging injury.

Anyone affected by cancer after taking Byetta is encouraged to speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Byetta lawsuits.

For more information on the research, side effects and litigation news related to Byetta and other drugs, or to speak with a lawyer, visit

*JPML, 4/29/13;
**Bloomberg, 2/25/13;
***Gastroenterology, July 2011;
****JAMA Internal Medicine, 2/25/13;
*****JPML, 4/5/13;

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Update: Warning Added to Pradaxa For Blood Condition
2. DrugRisks Update: Use of NuvaRing Drops Amid Injury Allegations
3. DrugRisk Update: New Study Warns of Cancer in Byetta Side Effects
4. DrugRisk Adds New Pancreatic Cancer Warning for Diabetes Drug Januvia
5. DrugRisks News Update: Bayer Loses Yaz Patent as Blood Clot Settlements Continue
6. DrugRisk Update: Court Asks for Pradaxa Lawsuit Test Cases
7. DrugRisks Adds Update From Court Ordering Mediation of Stryker Hip Lawsuits
8. DrugRisk Announces Launch of Byetta Cancer Resource Center
9. DrugRisks Update: Federal Court Schedules First Mirena Lawsuit Hearing
10. DrugRisk Announces Addition of Januvia Cancer Resource Center
11. DrugRisks Legal Update: Jury to Decide Actos Cancer Trial This Week
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... ... extremely stressful. At the VA Maryland Health Care System, the Caregiver Support ... patients. “Caregivers have a difficult job. Seventy-four percent report that their role ...
(Date:11/30/2015)... ... 30, 2015 , ... According to research by the National ... technicians to be certified or obtain continuing education. To increase awareness of the ... Mouth?” campaign to inform dentists that the technicians they trust could lack the ...
(Date:11/30/2015)... ... November 30, 2015 , ... The Museum ... summer, ushering in a new era of publicly accessible automated technology. Now, by ... continue to offer guests an up-close look at the shuttle at MOSI’s main ...
(Date:11/30/2015)... Alexandria, VA (PRWEB) , ... November 30, 2015 ... ... the mesothelioma-affected community across the United States to access life-saving information ... on Malignant Mesothelioma will consist of three individual conferences in three major ...
(Date:11/30/2015)... ... 30, 2015 , ... Rick Sommer, president of Intellitec Solutions, ... of Information Systems course. Based in Wilmington Delaware, Intellitec Solutions is an established ... student in the Enterprise Resource Planning (ERP) Systems class. The course focuses on ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... décembre 2015 MEDTEC Japon ... conférence d,Asie portant sur la conception ... manufacturière, se tiendra à ... 22 avril 2016. ... Photo - Logo ...
(Date:11/30/2015)... -- Nevro Corp. (NYSE: NVRO ), a global medical ... treatment of chronic pain, today announced that the Patent Trial ... Office (USPTO) has denied instituting an inter partes ... --> --> On ... two petitions challenging the validity of certain claims of the ...
(Date:11/30/2015)... 2015 Next week, December 2-3, BIOMEDevice ... ) co-located events covering the latest in Medtech innovation, ... will draw more than 3,000 design industry professionals to ... The events, combined show floor will host more than ... --> --> BIOMEDevice features suppliers ...
Breaking Medicine Technology: